Inducible site-specific recombination in myelinating cells

Genesis (United States)

Volumn 35, Issue 1, 2003, Pages 63-72

  Doerflinger, Nathalie H ^a   Macklin, Wendy B ^b   Popko, Brian ^c,d  

^a CNRS   (France)

^b LERNER RESEARCH INSTITUTE   (United States)

^c The University of Chicago Pritzker School of Medicine   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

CreERT; Myelinating cells; Recombination

Indexed keywords

BETA GALACTOSIDASE; CRE RECOMBINASE; CYTOPLASM PROTEIN; ESTROGEN RECEPTOR; HYBRID PROTEIN; PROTEOLIPID PROTEIN; TAMOXIFEN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELLULAR DISTRIBUTION; GENE EXPRESSION; GENE FUNCTION; GENETIC RECOMBINATION; MOUSE; MYELIN SHEATH; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REGULATORY SEQUENCE; REPORTER GENE; SCHWANN CELL; SOMATIC MUTATION; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0037247647     PISSN: 1526954X     EISSN: None     Source Type: Journal    
DOI: 10.1002/gene.10154     Document Type: Article

References (32)

1. Araki K, Araki M, Miyazaki J, Vassalli P. 1995. Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc Natl Acad Sci USA 92:160-164.
2. Baumann N, Pham-Dinh D. 2001. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871-927.
3. Belachew S, Yuan X, Gallo V. 2001. Unraveling oligodendrocyte origin and function by cell-specific transgenesis. Dev Neurosci 23:287-298.
4. Campagnoni CW, Garbay B, Micevych P, Pribyl T, Kampf K, Handley VW, Campagnoni AT. 1992. DM20 mRNA splice product of the myelin proteolipid protein gene is expressed in the murine heart. J Neurosci Res 33:148-155.
5. Duncan ID, Grever WE, Zhang SC. 1997. Repair of myelin disease: strategies and progress in animal models. Mol Med Today 3:554-561.
6. Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P. 1996. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci USA 93:10887-10890.
7. Feltri ML, D'Antonio M, Previtali S, Fasolini M, Messing A, Wrabetz L. 1999. PO-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells. Ann N Y Acad Sci 883:116-123.
8. Fuss B, Mallon B, Phan T, Ohlemeyer C, Kirchhoff F, Nishiyama A, Macklin WB. 2000. Purification and analysis of in vivo-differentiated oligodendrocytes expressing the green fluorescent protein. Dev Biol 218:259-274.
9. Fuss B, Afshari FS, Colello RJ, Macklin WB. 2001. Normal CNS myelination in transgenic mice overexpressing MHC class I H-2L(d) in oligodendrocytes. Mol Cell Neurosci 18:221-234.
10. Gao X, Kemper A, Popko B. 1999. Advanced transgenic and gene-targeting approaches. Neurochem Res 24:1183-1190.
11. Garbay B, Heape AM, Sargueil F, Cassagne C. 2000. Myelin synthesis in the peripheral nervous system. Prog Neurobiol 61:267-304.
12. Griffiths I, Klugmann M, Anderson T, Thomson C, Vouyiouklis D, Nave KA. 1998. Current concepts of PLP and its role in the nervous system. Microsc Res Tech 41:344-358.
13. Hisahara S, Araki T, Sugiyama F, Yagami K, Suzuki M, Abe K, Yamamura K, Miyazaki J, Momoi T, Saruta T, Bernard CC, Okano H, Miura M. 2000. Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination. EMBO J 19:341-348.
14. Jiang H, Duchala CS, Awatramani R, Shumas S, Carlock L, Kamholz J, Garbern J, Scherer SS, Shy ME, Macklin WB. 2000. Proteolipid protein mRNA stability is regulated by axonal contact in the rodent peripheral nervous system. J Neurobiol 44:7-19.
15. Kellendonk C, Tronche F, Monaghan AP, Angrand PO, Stewart F, Schutz G. 1996. Regulation of Cre recombinase activity by the synthetic steroid RU 486. Nucleic Acids Res 24:1404-1411.
16. Kellendonk C, Tronche F, Casanova E, Anlag K, Opherk C, Schutz G. 1999. Inducible site-specific recombination in the brain. J Mol Biol 285:175-182.
17. Kuhn R, Schwenk F, Aguet M, Rajewsky K. 1995. Inducible gene targeting in mice. Science 269:1427-1429.
18. Mallon BS, Shick HE, Kidd GJ, Macklin WB. 2002. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J Neurosci 22:876-885.
19. Martini R. 2000. Animal models for inherited peripheral neuropathies: chances to find treatment strategies? J Neurosci Res 61:244-250.
20. Metzger D, Clifford J, Chiba H, Chambon P. 1995. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc Natl Acad Sci USA 92:6991-6995.
21. Morell P, Quarles RH, 1999. Myelin formation, structure, and biochemistry. In: Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD, editors. Basic neurochemistry: molecular, cellular, and medical aspects. Philadelphia: Lippincott-Raven Press. p 69-93.
22. Nagy A. 2000. Cre recombinase: the universal reagent for genome tailoring. genesis 26:99-109.
23. Niwa-Kawakita M, Abramowski V, Kalamarides M, Thomas G, Giovannini M. 2000. Targeted expression of Cre recombinase to myelinating cells of the central nervous system in transgenic mice. genesis 26:127-129
24. Puckett C, Hudson L, Ono K, Friedrich V, Benecke J, Dubois-Dalcq M, Lazzarini RA. 1987. Myelinn-specific proteolipid protein is expressed in myelinating Schwann cells but is not incorporated into myelin sheaths. J Neurosci Res 18:511-518.
25. Sato M, Watanabe T, Oshida A, Nagashima A, Miyazaki JI, Kimura M. 2001. Usefulness of double gene construct for rapid identification of transgenic mice exhibiting tissue-specific gene expression. Mol Reprod Dev 60:446-456.
26. Sauer B, Henderson N. 1989. Cre-stimulated recombination at loxP-containing DNA sequences placed into the mammalian genome. Nucleic Acids Res 17:147-161.
27. Scherer SS. 1997. Molecular genetics of demyelination: new wrinkles on an old membrane. Neuron 18:13-16.
28. Spassky N, Goujet-Zalc C, Parmantier E, Olivier C, Martinez S, Ivanova A, Ikenaka K, Macklin W, Cerruti I, Zalc B, Thomas JL. 1998. Multiple restricted origin of oligodendrocytes. J Neurosci 18:8331-8343.
29. Suter U, Nave KA. 1999. Transgenic mouse models of CMT1A and HNPP. Ann N Y Acad Sci 883:247-253.
30. Yool DA, Edgar JM, Montague P, Malcolm S. 2000. The proteolipid protein gene and myelin disorders in man and animal models. Hum Mol Genet 9:987-992.
31. Werner H, Jung M, Klugmann M, Sereda M, Griffiths IR, Nave KA. 1998. Mouse models of myelin diseases. Brain Pathol 8:771-793.
32. Wight PA, Duchala CS, Readhead C, Macklin WB. 1993. A myelin proteolipid protein-LacZ fusion protein is developmentally regulated and targeted to the myelin membrane in transgenic mice. J Cell Biol 123:443-454.